# L-Alliin Modulates Brain Region-Specific Neuroinflammatory Responses to Lipopolysaccharide in Diet-Induced Obese Mice

**Authors:** Celia González-Castillo, Daniel Ortuño-Sahagún, Carolina Guzmán-Brambila, Daniel Ulises Torres-Reyes, Lucrecia Carrera-Quintanar, Oscar Arias-Carrión

PMC · DOI: 10.3390/brainsci16020243 · Brain Sciences · 2026-02-22

## TL;DR

L-alliin reduces brain inflammation in obese mice, especially in the frontal cortex and hypothalamus, suggesting it could help treat obesity-related brain inflammation.

## Contribution

L-alliin shows brain region- and diet-dependent anti-inflammatory effects in neuroinflammation.

## Key findings

- High-fat diets increase LPS-induced inflammation in the frontal cortex and hypothalamus.
- L-alliin reduces cytokine levels more effectively in high-fat diet-fed mice.
- The hippocampus shows distinct, less responsive patterns to L-alliin and diet.

## Abstract

What are the main findings?
A high-fat diet markedly amplifies LPS-induced neuroinflammatory responses in a brain-region-specific manner, especially in the frontal cortex and hypothalamus.L-alliin significantly reduces cytokine overactivation, with stronger anti-inflammatory effects in metabolically stressed (HFD-fed) animals.

A high-fat diet markedly amplifies LPS-induced neuroinflammatory responses in a brain-region-specific manner, especially in the frontal cortex and hypothalamus.

L-alliin significantly reduces cytokine overactivation, with stronger anti-inflammatory effects in metabolically stressed (HFD-fed) animals.

What are the implications of the main findings?
L-alliin acts as a context-dependent modulator, selectively normalizing cytokine pathways according to the metabolic load and neural region involved.These results support the therapeutic potential of L-alliin for targeting obesity-related neuroinflammation and highlight the need for region-specific strategies in CNS immunometabolic disorders.

L-alliin acts as a context-dependent modulator, selectively normalizing cytokine pathways according to the metabolic load and neural region involved.

These results support the therapeutic potential of L-alliin for targeting obesity-related neuroinflammation and highlight the need for region-specific strategies in CNS immunometabolic disorders.

Background/Objectives: A high-fat diet disrupts metabolic and neuroimmune balance in the brain, making neural tissue more reactive to inflammatory challenges. However, it is not well understood how this vulnerability varies across brain regions or how natural anti-inflammatory compounds influence it. Methods: In this study, we examined how the garlic-derived molecule L-alliin modulates the inflammatory response triggered by lipopolysaccharide in the frontal cortex, hippocampus, and hypothalamus of mice fed either a standard or high-fat diet. Results: Measurements of cytokine gene expression showed that the high-fat diet greatly increased the inflammatory response in the frontal cortex and hypothalamus, with the hypothalamus displaying the strongest overall activation. Treatment with L-alliin significantly reduced elevated cytokine levels in both regions, with the reductions most pronounced in animals on the high-fat diet. In contrast, the hippocampus showed a distinct pattern: expression of TNF-α and IL-1β changed very little across diets or treatments, whereas IL-6 and CCL2 were selectively altered by L-alliin, depending on the animals’ metabolic state. Conclusions: These findings demonstrate that diet-induced obesity does not affect the entire brain uniformly. Instead, inflammatory pathways are altered region-specifically, and L-alliin modulates these pathways with sensitivity to both brain region and metabolic condition. This work emphasizes the importance of accounting for neuroanatomical differences when developing strategies to reduce inflammation in obesity-associated conditions.

## Linked entities

- **Proteins:** TNF (tumor necrosis factor), IL1B (interleukin 1 beta), IL6 (interleukin 6), CCL2 (C-C motif chemokine ligand 2)
- **Chemicals:** L-alliin (PubChem CID 87310)
- **Diseases:** obesity (MONDO:0011122)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Actb (actin, beta) [NCBI Gene 11461] {aka Actx, E430023M04Rik, beta-actin}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, Slc7a5 (solute carrier family 7 (cationic amino acid transporter, y+ system), member 5) [NCBI Gene 20539] {aka 4F2LC, D0H16S474E, Gm42049, LAT1, TA1}, Tnfrsf1b (tumor necrosis factor receptor superfamily, member 1b) [NCBI Gene 21938] {aka CD120b, TNF-R-II, TNF-R2, TNF-R75, TNF-alphaR2, TNFBR}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Ocln (occludin) [NCBI Gene 18260] {aka Ocl}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Ccl2 (C-C motif chemokine ligand 2) [NCBI Gene 20296] {aka HC11, JE, MCAF, MCP-1, MCP1, SMC-CF}, Tlr4 (toll-like receptor 4) [NCBI Gene 21898] {aka Lps, Ly87, Ran/M1, Rasl2-8}, Ikbkb (inhibitor of kappaB kinase beta) [NCBI Gene 16150] {aka IKK-2, IKK-B, IKK-beta, IKK2, IKK[b], IKKbeta}
- **Diseases:** DIO (MESH:D009765), depression (MESH:D003866), neuronal injury (MESH:D009410), weight gain (MESH:D015430), HFD (MESH:D004620), inflammatory storm (MESH:C566109), septic shock (MESH:D012772), cognitive and structural impairments (MESH:D003072), immunometabolic disorders (MESH:D009358), metabolic syndrome (MESH:D024821), neurodegeneration (MESH:D019636), injury to (MESH:D014947), CNS inflammation (MESH:D007249), neurotoxic (MESH:D020258), infection (MESH:D007239), Neuroinflammation (MESH:D000090862), BBB (MESH:C536830), toxicity (MESH:D064420)
- **Chemicals:** L (MESH:D007930), LPS (MESH:D008070), free fatty acids (MESH:D005230), saline (MESH:D012965), fat (MESH:D005223), diallyl disulfide (MESH:C028009), SYBR (-), silica (MESH:D012822), nitrogen (MESH:D009584), carbohydrate (MESH:D002241), Alliin (MESH:C006453)
- **Species:** Allium sativum (garlic, species) [taxon 4682], Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606], Rodentia (rodent, order) [taxon 9989]
- **Cell lines:** C57BL/6J — Mus musculus (Mouse), Transformed cell line (CVCL_C0MW)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12938804/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12938804/full.md

## References

32 references — full list in the complete paper: https://tomesphere.com/paper/PMC12938804/full.md

---
Source: https://tomesphere.com/paper/PMC12938804